(24) found that the frequency of CD4+ TSCM cells was higher in the lymph nodes and peripheral blood of lung cancer patients than in healthy controls, and their absolute value in lymph nodes was significantly higher than that in peripheral blood. The gene discussed is CD4; the disease is lung carcinoma.